Potential use of early alterations in μ and δ opioid receptors as a predictive index for delayed brain ischemic damage

Neurobiology of Disease

Volumn 13, Issue 1, 2003, Pages 63-73

  Boutin, Hervé ^a,c   Jauzac, Philippe ^a   MacKenzie, Eric T ^a   Dauphin, François ^a,b  

^a UNIVERSITÉ DE CAEN   (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; CONTROLLED STUDY; HISTOPATHOLOGY; MOUSE; NEUROCHEMISTRY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; TRANSIENT ISCHEMIC ATTACK;

EID: 0038737901     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(03)00033-0     Document Type: Article

References (56)

1. 3H]glycine binding in the gerbil brain after cerebral ischemia. Eur. J. Pharmacol. 278:1995;91-96.
2. Arvidsson U., Riedl M., Chakrabarti S., Vulchanova L., Lee J.-H., Nakano A.H., Lin X., Loh H.H., Law P.-Y., Wessendorf M.W., Elde R. The κ-opioid receptor is primarily postsynaptic combined immunohistochemical localization of the receptor and endogenous opioids . Proc. Natl. Acad. Sci. USA. 92:1995;5062-5066.
3. Baskin D.S., Widmayer M.A., Browning J.L., Heizer M.L., Schmidt W.K. Evaluation of delayed treatment of focal cerebral ischemia with three selective κ-opioid agonists in cats. Stroke. 25:1994;2047-2053.
4. Berry M.M., Standring S.M., Bannister L.H. Nervous system. Williams P.L. Gray's Anatomy. 3rd ed. 1995;Churchill Livingstone, London, UK.
5. Boutin H., Dauphin F., Jauzac P.h., MacKenzie E.T. Exofocal alterations in opioidergic receptor densities following focal cerebral ischaemia in mice. Exp. Neurol. 164:2000;314-321.
6. Boutin H., Dauphin F., MacKenzie E.T., Jauzac P.h. Cortical and subcortical alterations of the opioidergic system in response to cerebral ischaemia. Krieglstein J., Oberpichler-Schwenk H. Pharmacology of Cerebral Ischemia. 1996;601-617 Medpharm Scientific Publishers Stuttgart, Stuttgart.
7. Boutin H., Dauphin F., MacKenzie E.T., Jauzac P.h. Differential time-course decreases in non-selective, mu, delta and kappa opioid receptors following focal cerebral ischemia in mice. Stroke. 30:1999;1271-1278.
8. Boutin H., Jauzac P.h., MacKenzie E.T., Dauphin F. Maximal densities of μ, δ and κ receptors are differentially altered by focal cerebral ischaemia in the mouse. Brain Res. 787:1998;237-241.
9. Britton P., May L.X., Laskosky M.S., Tortella F.C. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats. Life Sci. 20:1997;1729-1740.
10. Commons K.G., Milner T.A. Cellular and subcellular localization of δ opioid receptor immunoreactivity in the rat dentate gyrus. Brain Res. 738:1996;181-195.
11. Commons K.G., Milner T.A. Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus. J. Comp. Neurol. 381:1997;373-387.
12. Drake C.T., Patterson T.A., Simmons M.I., Chavkin C., Milner T.A. Kappa Opioid receptor-like immunoreactivity in guinea pig brain ultrastructural localization in presynaptic terminals in hippocampal formation . J. Comp. Neurol. 370:1996;377-395.
13. Fukuyama N., Takizawa S., Ishida H., Hoshiai K., Shinohara Y., Nakazawa H. Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region. J. Cereb. Blood Flow Metab. 18:1998;123-129.
14. Garcia J.H., Liu K.-F., Ho K.-L. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke. 26:1995;636-643.
15. Garcia J.H., Yoshida Y., Chen H., Li Y., Zhang Z.G., Lian J., Chen S., Chopp M. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am. J. Pathol. 142:1993;623-635.
16. Gartshore G., Dawson Patterson J., Macrae I.M. Consequences of transient focal cerebral ischaemia for second messenger and neurotransmitter binding in the rat quantitative autoradiographic analysis of forskolin, dopamine D1 receptor binding and cerebral blood flow changes . Eur. J. Neurosci. 8:1996;486-493.
17. Gracy K.N., Svingos A.L., Pickel V.M. Dual ultrastructural localization of μ-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. J. Neurosci. 17:1997;4839-4848.
18. Guéniau C., Oberlander C. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. J. Pharmacol. Exp. Ther. 282:1997;1-6.
19. 3H]phorbol-12,13-dibutyrate binding autoradiography. Brain Res. 774:1997;69-76.
20. Heiss W.D., Graf R., Löttgen J., Ohta K., Fujita T., Wagner R., Grond M., Weinhard K. Repeat positron emission tomographic studies in transient middle cerebral artery occlusion in cats residual perfusion and efficacy of postischemic reperfusion . J. Cereb. Blood Flow Metab. 17:1997;388-400.
21. Heiss W.D., Grond M., Thiel A., Ghaemi M., Sobesky J., Rudolf J., Bauer B., Wienhard K. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke. 29:1998;454-461.
22. 2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke. 31:2000;366-369.
23. Heiss W.D., Kracht L.W., Thiel A., Grond M., Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain. 124:2001;20-29.
24. Kaplan B., Brint S., Tanabe J., Jacewicz M., Wang X.J., Pulsinelli W. Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke. 22:1991;1032-1039.
25. Korematsu K., Goto S., Nagahiro S., Ushio Y. Changes of immunoreactivity for synaptophysin (protein p38) following a transient cerebral ischemia in the rat striatum. Brain Res. 616:1993;320-324.
26. Lehman A. Atlas Stéréotaxique du Cerveau de la Souris. 1974;CNRS, Paris.
27. Lever J.R., Ilgin N., Musachio J.L., Scheffel U., Finley P.A., Flesher J.E., Natarajan T.K., Wagner H.N., Frost J.J. Autoradiographic and SPECT imaging of cerebral opioid receptors with an iodine-123 labeled analogue of diprenorphine. Synapse. 29:1998;172-182.
28. Liu P.K., Hsu C.Y., Dizdaroglu M., Floyd R.A., Kow Y.W., Karakaya A., Rabow L.E., Cui J.-K. Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J. Neurosci. 16:1996;6795-6806.
29. Mackay K.B., Kusumoto K., Graham D.I., McCulloch J. The effect of a kappa opioid agonist in experimental focal cerebral ischemia. Krieglstein J.H., Oberpichler-Schwenk H. Pharmacology of Cerebral Ischemia. 1992;207-215 Medpharm Scientific Publishers Stuttgart, Stuttgart.
30. MacManus J.P., Linnik M.D. Gene expression induced by cerebral ischemia an apoptotic perspective . J. Cereb. Blood Flow Metab. 17:1997;815-832.
31. Madar I., Lesser R.P., Krauss G., Zubieta J.K., Lever J.R., Kinter C.M., Ravert H.T., Musachio J.L., Mathews W.B., Dannals R.F., Frost J. Imaging of δ- and μ-opioid receptors in temporal lobe epilepsy by positron emission tomography Ann. Neurol. 41:1997;358-367.
32. Mao Y., Yang G., Zhou L. Temporary and permanent focal cerebral ischemia in the mouse assessment of cerebral blood flow, brain damage and blood-brain barrier permeability . Chin. Med. J. (Engl.). 113:2000;361-366.
33. Matsumoto K., Lo E.L., Pierce A.L., Halpem E.F., Newcomb R. Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16:1996;114-124.
34. Mayfield K.P., Kozak W., Malvin G.M., Porreca F. Hypoxia decreases opioid delta receptor expression in mouse brain. Neuroscience. 72:1996;785-789.
35. McLean S., Rothman R.B., Herckenham M. Autoradiographic localization of Mu and Delta opiate receptors in the forebrain of the rat. Brain Res. 378:1986;49-60.
36. Moyse E., Marcel D., Leonard K., Beaudet A. Electron microscopic distribution of mu opioid receptors on noradrenergic neurons of the locus coeruleus. Eur. J. Neurosci. 9:1997;128-139.
37. Murakami K., Kondo T., Chan P.H. Reperfusion following focal cerebral ischemia alters distribution of neuronal cells with DNA fragmentation in mice. Brain Res. 751:1997;160-164.
38. Nakanishi H., Kawai K., Tamura A. Electrophysiological changes in substantia nigra neurons after middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 17:1997;S657. (Abstract).
39. Olive M.F., Anton B., Micevych P., Evans C.J., Maidment N.T. Presynaptic versus postsynaptic localization of μ and δ opioid receptors in dorsal and ventral striatopallidal pathways. J. Neurosci. 17:1997;7471-7479.
40. Peters O., Back T., Lindauer U., Busch C., Megow D., Dreier J., Dirnagl U. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 18:1998;196-205.
41. Piantadosi C.A., Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke. 27:1996;327-332.
42. 2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br. J. Pharmacol. 122:1997;520-524.
43. Sette G., Baron J.C., Young A.R., Miyazawa H., Tillet I., Barré L., Travère J.M., Derlon J.M., MacKenzie E.T. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke. 24:1993;2046-2057.
44. Simmons M.L., Chavkin C. κ-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release. Mol. Pharmacol. 50:1996;80-85.
45. Slivka A.P., Murphy E.J. High-dose methylprednisolone treatment in experimental focal cerebral ischemia. Exp. Neurol. 167:2001;166-172.
46. 11C]methyl) naltrindole and positron emission tomography. J. Cereb. Blood Flow Metab. 19:1999;956-966.
47. Stroemer R.P., Kent T.A., Hulsebosch C.E. Neocortical neural sprouting, synaptogenesis, and behvioral recovery after neocortical infarction in rats. Stroke. 26:1995;2135-2144.
48. Svingos A.L., Cheng P.Y., Clarke C.L., Pickel V.M. Ultrastructural localization of δ-opioid receptor and Met-enkephalin immunoreactivity in rat insular cortex. Brain Res. 700:1995;25-39.
49. Svingos A.L., Moriwaki A., Wang J.B., Uhl G.R., Pickel V.M. Ultrastructural immunocytochemical localization of μ-opioid receptors in rat nucleus accumbens extrasynaptic plasmalemmal distribution and association with Leu-enkephalin . J. Neurosci. 16:1996;4162-4173.
50. Wagner J.J., Caudle R.M., Chavkin C. κ-Opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J. Neurosci. 12:1992;132-141.
51. Waksman G., Hamel E., Delay-Goyet P., Roques B.P. Neutral endopeptidase-24.11, μ and δ opioid receptors after selective brain lesions an autoradiographic study . Brain Res. 436:1987;205-216.
52. Wang H., Moriwaki A., Wang J.B., Uhl G.R., Pickel V.M. Ultrastructural immunocytochemical localization of μ opioid receptors and Leu-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J. Comp. Neurol. 375:1996;659-674.
53. Wang R.F., Tafani J.A., Zajac J.M., Guiraud R. A radioiodinated 7alpha-O-iodoallyl diprenorphine for mapping opioid receptors. Neuropeptides. 33:1999;498-502.
54. Welsh F.A., Sakamoto T., McKee A.E., Sims R.E. Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J. Neurochem. 49:1987;846-851.
55. Young A.R., Touzani O., Derlon J.M., Sette G., MacKenzie E.T., Baron J.-C. Early reperfusion in the anaethetized baboon reduces brain damage following middle cerebral artery occlusion. Stroke. 28:1997;632-638.
56. Zhang J.-P., Sun G.Y. Free fatty acids, neutral glycerides, and phosphoglycerides in transient focal cerebral ischemia. J. Neurochem. 64:1995;1688-1695.